Jail-Based Impact of Crime Intervention (IOC)

May 3, 2013 updated by: June Tangney, George Mason University

Phase 2 RCT of Jail-Based Impact of Crime Intervention to Reduce Recidivism, Substance Abuse and HIV Risk Behavior

The purpose of this study is to evaluate whether the Impact of Crime (IOC) group intervention with jail inmates reduces post-release recidivism, substance abuse, and HIV risk behavior.

Study Overview

Detailed Description

This project imports social-personality theory and research on moral emotions and cognitions to the applied problems of crime, substance abuse, and HIV risk behavior. The primary aim of this study, a Phase 2 Randomized Clinical Trial (RCT) of the restorative justice-inspired Impact of Crime (IOC) group intervention, is to examine the efficacy of treatment and to determine if changes in moral emotions and cognitions serve as mechanisms of action, explaining the impact of treatment involvement on reductions in post-release recidivism, substance abuse, and HIV risk behavior.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Fairfax, Virginia, United States, 22030
        • Fairfax County Adult Detention Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Sentence must be short enough to serve out sentence at ADC
  • Release date must follow projected final session of treatment
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MI plus IOC group intervention
45 minute Motivational Interview plus 16 session IOC intervention
Other Names:
  • Impact of Crime
Experimental: Motivational Interview only
45 minute Motivational Interview session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Recidivism - Self report of arrests and undetected crimes
Time Frame: 3 months post-release
3 months post-release
Recidivism - Self report of arrests and undetected crimes
Time Frame: 1 yr post-release
1 yr post-release
Recidivism - Self report of arrests and undetected crimes
Time Frame: 3 yr post-release
3 yr post-release
Recidivism - Self report of arrests and undetected crimes
Time Frame: 5 yr post-release
5 yr post-release
Recidivism -- official FBI records of arrests
Time Frame: 1 yr post-release
1 yr post-release
Recidivism -- official FBI records of arrests
Time Frame: 3 yr post-release
3 yr post-release
Recidivism -- official FBI records of arrests
Time Frame: 5 yr post-release
5 yr post-release

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes in self-reported shame-proneness from baseline
Time Frame: changes from baseline to post tx and 3 mo, 1 yr, 3yr and 5 yr post-release
changes from baseline to post tx and 3 mo, 1 yr, 3yr and 5 yr post-release
Changes in self-reported guilt proneness from baseline
Time Frame: changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release
changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release
Changes from self-reported empathy from baseline
Time Frame: changes from baseline to post tx, 3 mo, 1 yr, 3 yr, 5 yr post-release
changes from baseline to post tx, 3 mo, 1 yr, 3 yr, 5 yr post-release
Changes from self-reported criminogenic thinking at baseline
Time Frame: changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release
changes from baseline to post tx, and 3 mo, 1 yr, 3 yr, 5 yr post-release
Changes in self-reported substance use and dependence from 1 yr pre-incarceration
Time Frame: changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release
changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release
Changes in self-reported HIV risk behavior (sex and IDU) from 1 year pre-incarceration
Time Frame: changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release
changes from pre-incarceration to 3 mo, 1 yr, 3 yr, 5 yr post-release

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: June P Tangney, Ph.D., George Mason University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

June 1, 2016

Study Registration Dates

First Submitted

June 17, 2011

First Submitted That Met QC Criteria

June 22, 2011

First Posted (Estimate)

June 23, 2011

Study Record Updates

Last Update Posted (Estimate)

May 7, 2013

Last Update Submitted That Met QC Criteria

May 3, 2013

Last Verified

May 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • R01DA014694-11 (U.S. NIH Grant/Contract)
  • R01DA014694 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Clinical Trials on MI plus IOC group intervention

Subscribe